Company Filing History:
Years Active: 2010
Title: The Innovations of Christopher Holmquist
Introduction
Christopher Holmquist is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmacology, particularly in the development of nicotinic acetylcholine receptor ligands. His work has implications for various therapeutic applications.
Latest Patents
Holmquist holds a patent for "Nicotinic acetylcholine receptor ligands 101." This patent details ligands of Formula I, including diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing, and methods for using the same. This innovation showcases his expertise in medicinal chemistry and receptor biology.
Career Highlights
Christopher Holmquist is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Holmquist has collaborated with notable colleagues, including Hui-Fang Chang and Eifion D Phillips. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Christopher Holmquist's contributions to the field of pharmacology through his patent and work at AstraZeneca AB highlight his role as an influential inventor. His innovations continue to pave the way for advancements in therapeutic solutions.